Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Hans-Jurgen Moller2 13rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Greece (Греция) 2Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany (Германия)
Список исп. литературыСкрыть список 1. Khan A, Leventhal RM, Khan SR et al. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol 2002;22:40-5. 2. Khan A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000;57:311-7. 3. Turner EH, Matthews AM, Linardatos E et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-60. 4. Kirsch I, Deacon BJ, Huedo-Medina TB et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 2008;5:e45. 5. Fournier JC, DeRubeis RJ, Hollon SD et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010;303:47-53. 6. Cipriani A, Furukawa TA, Salanti G et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multipletreatments meta-analysis. Lancet 2009;373:746-58. 7. Gartlehner G, Gaynes BN, Hansen RA et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med 2008;149:734-50. 8. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year metaanalytic review. Neuropsychopharmacology 2012;37:851-64. 9. Khan A, Faucett J, Lichtenberg P et al. A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 2012;7:e41778. 10. Kirsch I. Antidepressants and the placebo response. Epidemiol Psichiatr Soc 2009;18:318-22. 11. Kirsch I. Antidepressant drugs ‘work’, but they are not clinically effective. Br J Hosp Med 2008;69:359. 12. Fountoulakis KN, Hoschl C, Kasper S et al. The media and intellectuals’ response to medical publications: the anti-depressants’ case. Ann Gen Psychiatry 2013;12:11. 13. Fountoulakis K, Moller H. Antidepressants vs. placebo: not merely a quantitative difference in response. Int J Neuropsychopharmacol 2011;14:1435-7. 14. Fountoulakis KN, Samara MT, Siamouli M. Burning issues in the meta-analysis of pharmaceutical trials for depression. J Psychopharmacol (in press). 15. Fountoulakis KN, M€oller HJ. Efficacy of antidepressants: a reanalysis and re-interpretation of the Kirsch data. Int J Neuropsychopharmacol 2011;14:405-12. 16. Horder J, Matthews P, Waldmann R. Placebo, Prozac and PLoS: significant lessons for psychopharmacology. J Psychopharmacol 2011;25:1277-88. 17. Fountoulakis KN, Veroniki AA, Siamouli M et al. No role for initial severity on the efficacy of antidepressants: results of a multimeta-analysis. Ann Gen Psychiatry 2013;12:26. 18. Leucht S, Hierl S, Kissling W et al. Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses. Br J Psychiatry 2012;200:97-106. 19. Tarr GP, Glue P, Herbison P. Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania – a systematic review and metaanalysis. J Affect Disord 2011;134:14-9. 20. Yildiz A, Vieta E, Leucht S et al. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology 2011;36:375-89.